| Protein kinase inhibitors’ classification using K-Nearest neighbor algorithm R Arian, A Hariri, A Mehridehnavi, A Fassihi, F Ghasemi Computational biology and chemistry 86, 107269, 2020 | 53 | 2020 |
| Fenofibrate-induced renal dysfunction, yes or no? F Emami, A Hariri, M Matinfar, M Nematbakhsh Journal of Research in Medical Sciences 25 (1), 39, 2020 | 15 | 2020 |
| Effect of adjunctive topical liposomal azithromycin on systemic azithromycin on Old World cutaneous leishmaniasis: a pilot clinical study B Abtahi-Naeini, S Hadian, F Sokhanvari, A Hariri, J Varshosaz, ... Iranian Journal of Pharmaceutical Research: IJPR 20 (2), 383, 2021 | 10 | 2021 |
| Anti-cancer activity of biotin-polyoxomolybdate bioconjugate MS Hosseini, SH Javanmard, L Rafiei, AA Hariri, N Dana, M Rostami Eur. J. Med. Oncol. 4 (1), 42, 2020 | 8 | 2020 |
| CRISPR technology: A versatile tool to model, screen, and reverse drug resistance in cancer S Shirani-Bidabadi, A Tabatabaee, N Tavazohi, A Hariri, AR Aref, ... European Journal of Cell Biology 102 (2), 151299, 2023 | 7 | 2023 |
| Circadian and immunity cycle talk in cancer destination: from biological aspects to in silico analysis M Mirian, A Hariri, M Yadollahi, M Kohandel Cancers 14 (6), 1578, 2022 | 7 | 2022 |
| Monastrol derivatives: in silico: and: in vitro: cytotoxicity assessments Z Bidram, H Sirous, GA Khodarahmi, F Hassanzadeh, N Dana, AA Hariri, ... Research in Pharmaceutical Sciences 15 (3), 249-262, 2020 | 7 | 2020 |
| Targeting vimentin: A multifaceted approach to combatting cancer metastasis and drug resistance A Tabatabaee, B Nafari, A Farhang, A Hariri, A Khosravi, A Zarrabi, ... Cancer and Metastasis Reviews 43 (1), 363-377, 2024 | 3 | 2024 |
| Artificial intelligence in detecting mandibular fractures: A review of literature MS Sehat, A Hariri, P Soltani, A Khademi Archives of Trauma Research 12 (2), 102-111, 2023 | 2 | 2023 |
| The circadian rhythm: an influential soundtrack in the diabetes story A Hariri, M Mirian, A Zarrabi, M Kohandel, M Amini-Pozveh, AR Aref, ... Frontiers in Endocrinology 14, 1156757, 2023 | 1 | 2023 |
| Peptide-based pegylated polyurethane nanoparticles for paclitaxel delivery in HeLa cancer cells: the art of the architecture design in nanocarriers F Rafiemanzelat, S Tafazoli, AA Hairi, J Varshosaz, M Mirian, ... Polymer Bulletin 80 (9), 10493-10531, 2023 | 1 | 2023 |
| < span data-contrast=" auto"> Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review T Shokrnejad-Namin, E Amini, M Amoozgar, A Hariri | | 2024 |
| Evaluating the Prognostic Potential of CA-125 and miRNA Levels in Endometriosis: A Narrative Review T Shokrnejad-Namin, M Amoozgar, A Hariri, E Amini Preprints, 2024 | | 2024 |
| Efficacy of adjunctive topical liposomal clarithromycin on systemic Glucantime in Old World cutaneous leishmaniasis: a pilot clinical study A Hakamifard, R Radmehr, F Sokhanvari, F Sherkat, A Hariri, J Varshosaz, ... Frontiers in Pharmacology 14, 1280240, 2023 | | 2023 |
| SARS-CoV-2 Variant-Specific mRNA Vaccine: Pros and Cons S Shahsavandi, AA Hariri Viral Immunology 36 (3), 186-202, 2023 | | 2023 |
| Fenofibrate-induced renal dysfunction, yes or no?(Mini Review) F EMAMI, A Hariri, M MATINFAR, M NEMATBAKHSH JOURNAL OF RESEARCH IN MEDICAL SCIENCES (JRMS) 25 (4), 0-0, 2020 | | 2020 |
| Rituximab associated necrosis: A case report F Ashtari, A Hakamifard, A Hariri, T Gholipour-Shahraki Multiple Sclerosis and Related Disorders 37, 101429, 2020 | | 2020 |
Mina MirianDepartment of Pharmaceutical Biotechnology, Isfahan University of Medical SciencesVerified email at pharm.mui.ac.ir
